
-
India, Pakistan ceasefire holds after early violations
-
Herbert seals Asian Tour win with final-hole heroics
-
Catholics gather to catch glimpse of Pope Leo XIV at St Peter's prayer
-
US-China talks resume as Trump hails 'total reset' in trade relations
-
Ukraine ready for Russia truce talks, Zelensky says
-
Jubilant Peruvians celebrate new pope at mass in adoptive city
-
Scottish refinery closure spells trouble for green transition
-
Convicted ex-Panama president Martinelli granted asylum in Colombia
-
IPL chiefs in talks about restart following ceasefire: reports
-
Navarrete beats Suarez on technical decision to keep title
-
Scans clear Wallabies fly-half Lolesio of serious back injury
-
Leo XIV to address faithful with St Peter's prayer
-
T-Wolves grab 2-1 NBA playoff series lead as Celtics get key win
-
Gaza war casts shadow over Cannes film festival
-
'Treasure hunt': tourists boost sales at Japan's Don Quijote stores
-
Cannes Festival: the films in competition
-
Cannes film festival: what to look out for
-
Jordan hospital treats war casualties from across Middle East
-
As Trump family's Gulf empire grows, rulers seek influence, arms, tech
-
S. Korea conservatives choose presidential candidate after last-minute chaos
-
Trump hails 'total reset' in US-China trade relations as talks continue
-
Film claims to name killer of slain journalist Shireen Abu Akleh
-
Under Trump pressure, Columbia University ends semester in turmoil
-
Putin proposes direct Ukraine talks but quiet on 30-day ceasefire
-
Trump hails US-China trade 'reset' after first day of talks
-
Jeeno leads Boutier by one at LPGA Americas Open
-
Lowry, Straka share lead at windy Truist
-
Messi suffers worst defeat in MLS as Miami fall again
-
Celtics overwhelm Knicks to pull within 2-1 in NBA playoff series
-
Toulouse crush Toulon to reach Top 14 semis as Castres pay tribute to Raisuqe
-
Marseille, Monaco clinch Champions League qualification from Ligue 1
-
'One of those days': Atletico record-breaker Sorloth hits four
-
Toulouse's Ntamack suffers concussion in Top 14, Willemse nears exit
-
Record-breaker Sorloth hits four as Atletico smash Real Sociedad
-
'Weight off my shoulders': Bayern's Kane toasts breakthrough title
-
Sinner grateful for 'amazing' support on Italian Open return from doping ban
-
Hamburg return to Bundesliga after seven-year absence
-
Toulouse's Ntamack suffers concussion in Top 14 clash
-
India, Pakistan reach ceasefire -- but trade claims of violations
-
'Long time coming': Bayern's Kane toasts breakthrough title
-
US, China conclude first day of trade talks in Geneva
-
Kane tastes first title as champions Bayern bid farewell to Mueller
-
Benfica deny Sporting to take Portuguese title race to wire
-
Sinner makes triumphant return from doping ban at Italian Open
-
Sinner wins at Italian Open in first match since doping ban
-
Leo XIV, new pope and 'humble servant of God', visits Francis's tomb
-
India claims Pakistan violated truce, says it is retaliating
-
Champions League race hots up as Man City held, Villa win
-
Kane tastes first title as champions Bayern see off Mueller
-
US envoy calls enrichment 'red line' ahead of new Iran talks

International fusion energy project faces delays, says chief
An international project in nuclear fusion may face "years" of delays, its boss has told AFP, weeks after scientists in the United States announced a breakthrough in their own quest for the coveted goal.
The International Thermonuclear Experimental Reactor (ITER) project seeks to prove the feasibility of fusion as a large-scale and carbon-free source of energy.
Installed at a site in southern France, the decades-old initiative has a long history of technical challenges and cost overruns.
Fusion entails forcing together the nuclei of light atomic elements in a super-heated plasma, held by powerful magnetic forces in a doughnut-shaped chamber called a tokamak.
The idea is that fusing the particles together from isotopes of hydrogen -- which can be extracted from seawater -- will create a safer and almost inexhaustible form of energy compared with splitting atoms from uranium or plutonium.
ITER'S previously-stated goal was to create the plasma by 2025.
But that deadline will have to be postponed, Pietro Barabaschi -- who in September became the project's director-general -- told AFP during a visit to the facility.
The date "wasn't realistic in the first place," even before two major problems surfaced, Barabaschi said.
One problem, he said, was wrong sizes for the joints of blocks to be welded together for the installation's 19-by-11-metre (62-by-36-feet) chamber.
The second was traces of corrosion in a thermal shield designed to protect the outside world from the enormous heat created during nuclear fusion.
Fixing the problems "is not a question of weeks, but months, even years," Barabaschi said.
A new timetable is to be worked out by the end of this year, he said, including some modification to contain the expected cost overrun, and to meet the French nuclear safety agency's security requirements.
Barabaschi said he hoped ITER would be able to make up for the delays as it prepares to enter the full phase, currently scheduled for 2035.
On December 13, US researchers working separately from ITER announced an important technical breakthrough.
Scientists at the Lawrence Livermore National Laboratory (LLNL) in California said they had used the world's largest laser to create, for the first time, a fusion reaction generating more energy than it took to produce.
"Some competition is healthy in any environment," Barabaschi said about the success.
"If tomorrow somebody found another breakthrough that would make my work redundant, I would be very happy," he added.
ITER was set in motion after a 1985 summit between US president Ronald Reagan and Soviet leader Mikhail Gorbachev.
Its seven partners are China, the European Union, India, Japan, South Korea, Russia and the United States.
Russia still participates in ITER despite the start of the Ukraine conflict.
In November it dispatched one of six giant magnets needed for the top part of the tokamak.
J.Bergmann--BTB